Cargando…

Clinical evaluation of AI-assisted screening for diabetic retinopathy in rural areas of midwest China

BACKGROUND: Although numerous studies have described the application of artificial intelligence (AI) in diabetic retinopathy (DR) screening among diabetic populations, studies among populations in rural areas are rare. The purpose of this study was to evaluate the application value of an AI-based di...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Shaofeng, Liu, Changyan, Li, Na, Wu, Yanrong, Li, Dongdong, Gao, Qingyue, Yuan, Ziyou, Li, Guanyan, Li, Huilin, Yang, Jianzhou, Fan, Shengfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560484/
https://www.ncbi.nlm.nih.gov/pubmed/36227905
http://dx.doi.org/10.1371/journal.pone.0275983
_version_ 1784807757137838080
author Hao, Shaofeng
Liu, Changyan
Li, Na
Wu, Yanrong
Li, Dongdong
Gao, Qingyue
Yuan, Ziyou
Li, Guanyan
Li, Huilin
Yang, Jianzhou
Fan, Shengfu
author_facet Hao, Shaofeng
Liu, Changyan
Li, Na
Wu, Yanrong
Li, Dongdong
Gao, Qingyue
Yuan, Ziyou
Li, Guanyan
Li, Huilin
Yang, Jianzhou
Fan, Shengfu
author_sort Hao, Shaofeng
collection PubMed
description BACKGROUND: Although numerous studies have described the application of artificial intelligence (AI) in diabetic retinopathy (DR) screening among diabetic populations, studies among populations in rural areas are rare. The purpose of this study was to evaluate the application value of an AI-based diagnostic system for DR screening in rural areas of midwest China. METHODS: In this diagnostic accuracy study, diabetes mellitus (DM) patients in the National Basic Public Health Information Systems of Licheng County and Lucheng County of Changzhi city from July to December 2020 were selected as the target population. A total of 7824 eyes of 3933 DM patients were enrolled in this screening; the patients included 1395 males and 2401 females, with an average age of 19–87 years (63±8.735 years). All fundus photographs were collected by a professional ophthalmologist under natural pupil conditions in a darkroom using the Zhiyuan Huitu fundus image AI analysis software EyeWisdom. The AI-based diagnostic system and ophthalmologists were tasked with diagnosing the photos independently, and the consistency rate, sensitivity and specificity of the two methods in diagnosing DR were calculated and compared. RESULTS: The prevalence rates of DR according to the ophthalmologist and AI diagnoses were 22.7% and 22.5%, respectively; the consistency rate was 81.6%. The sensitivity and specificity of the AI system relative to the ophthalmologists’ grades were 81.2% (95% confidence interval [CI]: 80.3% 82.1%) and 94.3% (95% CI: 93.7% 94.8%), respectively. There was no significant difference in diagnostic outcomes between the methods (χ2 = 0.329, P = 0.566, P>0.05), and the AI-based diagnostic system had high consistency with the ophthalmologists’ diagnostic results (κ = 0.752). CONCLUSION: Our research demonstrated that DR patients in rural area hospitals can be screened feasibly. Compared with that of the ophthalmologists, however, the accuracy of the AI system must be improved. The results of this study might lend support to the large-scale application of AI in DR screening among different populations.
format Online
Article
Text
id pubmed-9560484
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-95604842022-10-14 Clinical evaluation of AI-assisted screening for diabetic retinopathy in rural areas of midwest China Hao, Shaofeng Liu, Changyan Li, Na Wu, Yanrong Li, Dongdong Gao, Qingyue Yuan, Ziyou Li, Guanyan Li, Huilin Yang, Jianzhou Fan, Shengfu PLoS One Research Article BACKGROUND: Although numerous studies have described the application of artificial intelligence (AI) in diabetic retinopathy (DR) screening among diabetic populations, studies among populations in rural areas are rare. The purpose of this study was to evaluate the application value of an AI-based diagnostic system for DR screening in rural areas of midwest China. METHODS: In this diagnostic accuracy study, diabetes mellitus (DM) patients in the National Basic Public Health Information Systems of Licheng County and Lucheng County of Changzhi city from July to December 2020 were selected as the target population. A total of 7824 eyes of 3933 DM patients were enrolled in this screening; the patients included 1395 males and 2401 females, with an average age of 19–87 years (63±8.735 years). All fundus photographs were collected by a professional ophthalmologist under natural pupil conditions in a darkroom using the Zhiyuan Huitu fundus image AI analysis software EyeWisdom. The AI-based diagnostic system and ophthalmologists were tasked with diagnosing the photos independently, and the consistency rate, sensitivity and specificity of the two methods in diagnosing DR were calculated and compared. RESULTS: The prevalence rates of DR according to the ophthalmologist and AI diagnoses were 22.7% and 22.5%, respectively; the consistency rate was 81.6%. The sensitivity and specificity of the AI system relative to the ophthalmologists’ grades were 81.2% (95% confidence interval [CI]: 80.3% 82.1%) and 94.3% (95% CI: 93.7% 94.8%), respectively. There was no significant difference in diagnostic outcomes between the methods (χ2 = 0.329, P = 0.566, P>0.05), and the AI-based diagnostic system had high consistency with the ophthalmologists’ diagnostic results (κ = 0.752). CONCLUSION: Our research demonstrated that DR patients in rural area hospitals can be screened feasibly. Compared with that of the ophthalmologists, however, the accuracy of the AI system must be improved. The results of this study might lend support to the large-scale application of AI in DR screening among different populations. Public Library of Science 2022-10-13 /pmc/articles/PMC9560484/ /pubmed/36227905 http://dx.doi.org/10.1371/journal.pone.0275983 Text en © 2022 Hao et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Hao, Shaofeng
Liu, Changyan
Li, Na
Wu, Yanrong
Li, Dongdong
Gao, Qingyue
Yuan, Ziyou
Li, Guanyan
Li, Huilin
Yang, Jianzhou
Fan, Shengfu
Clinical evaluation of AI-assisted screening for diabetic retinopathy in rural areas of midwest China
title Clinical evaluation of AI-assisted screening for diabetic retinopathy in rural areas of midwest China
title_full Clinical evaluation of AI-assisted screening for diabetic retinopathy in rural areas of midwest China
title_fullStr Clinical evaluation of AI-assisted screening for diabetic retinopathy in rural areas of midwest China
title_full_unstemmed Clinical evaluation of AI-assisted screening for diabetic retinopathy in rural areas of midwest China
title_short Clinical evaluation of AI-assisted screening for diabetic retinopathy in rural areas of midwest China
title_sort clinical evaluation of ai-assisted screening for diabetic retinopathy in rural areas of midwest china
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560484/
https://www.ncbi.nlm.nih.gov/pubmed/36227905
http://dx.doi.org/10.1371/journal.pone.0275983
work_keys_str_mv AT haoshaofeng clinicalevaluationofaiassistedscreeningfordiabeticretinopathyinruralareasofmidwestchina
AT liuchangyan clinicalevaluationofaiassistedscreeningfordiabeticretinopathyinruralareasofmidwestchina
AT lina clinicalevaluationofaiassistedscreeningfordiabeticretinopathyinruralareasofmidwestchina
AT wuyanrong clinicalevaluationofaiassistedscreeningfordiabeticretinopathyinruralareasofmidwestchina
AT lidongdong clinicalevaluationofaiassistedscreeningfordiabeticretinopathyinruralareasofmidwestchina
AT gaoqingyue clinicalevaluationofaiassistedscreeningfordiabeticretinopathyinruralareasofmidwestchina
AT yuanziyou clinicalevaluationofaiassistedscreeningfordiabeticretinopathyinruralareasofmidwestchina
AT liguanyan clinicalevaluationofaiassistedscreeningfordiabeticretinopathyinruralareasofmidwestchina
AT lihuilin clinicalevaluationofaiassistedscreeningfordiabeticretinopathyinruralareasofmidwestchina
AT yangjianzhou clinicalevaluationofaiassistedscreeningfordiabeticretinopathyinruralareasofmidwestchina
AT fanshengfu clinicalevaluationofaiassistedscreeningfordiabeticretinopathyinruralareasofmidwestchina